Patents by Inventor Michael Andreas Schafroth

Michael Andreas Schafroth has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240131032
    Abstract: Disclosed herein are methods, pharmaceutical compositions, and vaccines for modulating an immune response. Also disclosed herein are methods, pharmaceutical compositions, and vaccines for inducing an immune response.
    Type: Application
    Filed: October 15, 2020
    Publication date: April 25, 2024
    Inventors: Benjamin CRAVATT, Ekaterina VINOGRADOVA, Vincent CROWLEY, Xiaoyu ZHANG, Michael Andreas SCHAFROTH, Minoru YOKOYAMA, Dave REMILLARD, Bruno MELILLO, Stuart SCHREIBER
  • Publication number: 20220373541
    Abstract: The present invention relates to tri-functional crosslinking reagents carrying (i) a ligand-reactive group for conjugation to a ligand of interest having at least one binding site on a target glycoprotein receptor, (ii) a hydrazone group for the capturing of oxidized receptor-glycoproteins and (iii) an affinity group selected from azides and aklynes for the detection, isolation and purification of captured glycoproteins; as well as their manufacturing. The invention further provides for improved methods of detecting, identifying and characterizing interactions between ligands and their corresponding target glycoproteins on living cells and in biological fluids. The invention further provides for new uses of catalysts in such methods.
    Type: Application
    Filed: July 8, 2022
    Publication date: November 24, 2022
    Applicant: ETH Zurich
    Inventors: Erick Moran Carreira, Michael Andreas Schafroth, Nadine Sobotzki, Bernd Wollscheid
  • Patent number: 11385225
    Abstract: The present invention relates to tri-functional crosslinking reagents carrying (i) a ligand-reactive group for conjugation to a ligand of interest having at least one binding site on a target glycoprotein receptor, (ii) a hydrazone group for the capturing of oxidized receptor-glycoproteins and (iii) an affinity group selected from azides and alkynes for the detection, isolation and purification of captured glycoproteins; as well as their manufacturing. The invention further provides for improved methods of detecting, identifying and characterizing interactions between ligands and their corresponding target glycoproteins on living cells and in biological fluids. The invention further provides for new uses of catalysts in such methods.
    Type: Grant
    Filed: November 9, 2016
    Date of Patent: July 12, 2022
    Assignee: ETH Zurich
    Inventors: Erick Moran Carreira, Michael Andreas Schafroth, Nadine Sobotzki, Bernd Wollscheid
  • Publication number: 20180328922
    Abstract: The present invention relates to tri-functional crosslinking reagents carrying (i) a ligand-reactive group for conjugation to a ligand of interest having at least one binding site on a target glycoprotein receptor, (ii) a hydrazone group for the capturing of oxidized receptor-glycoproteins and (iii) an affinity group selected from azides and alkynes for the detection, isolation and purification of captured glycoproteins; as well as their manufacturing. The invention further provides for improved methods of detecting, identifying and characterizing interactions between ligands and their corresponding target glycoproteins on living cells and in biological fluids. The invention further provides for new uses of catalysts in such methods.
    Type: Application
    Filed: November 9, 2016
    Publication date: November 15, 2018
    Inventors: Erick Moran Carreira, Michael Andreas Schafroth, Nadine Sobotzki, Bernd Wollscheid